Australia markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
131.82-0.48 (-0.36%)
At close: 04:00PM EDT
129.00 -2.82 (-2.14%)
After hours: 07:54PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121314
Avg. Estimate-0.061.073.6111.54
Low estimate-0.430.040.91.33
High estimate0.542.596.325.35
Year ago EPS-0.27-0.46-5.83.61
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts16151919
Avg. Estimate384.67M501.82M1.9B2.88B
Low estimate365.6M415.5M1.66B1.8B
High estimate435M705.54M2.42B4.4B
Year ago sales261.24M331.82M1.24B1.9B
Sales growth (year/est)47.20%51.20%52.90%51.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.78-1.230.01-0.07
Actual EPS-0.27-0.460.470.37
Difference1.510.770.460.44
Surprise %84.80%62.60%4,600.00%628.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.061.073.6111.54
7 days ago-0.051.013.3910.8
30 days ago-0.070.732.4311.04
60 days ago-0.060.722.1310.16
90 days ago0.440.872.9810.16
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1234
Up last 30 days9101210
Down last 7 daysN/AN/AN/AN/A
Down last 30 days211N/A
Growth estimatesSRPTIndustrySector(s)S&P 500
Current qtr.77.80%N/AN/AN/A
Next qtr.332.60%N/AN/AN/A
Current year162.20%N/AN/AN/A
Next year219.70%N/AN/AN/A
Next 5 years (per annum)96.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A